Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
10/2014
10/02/2014US20140296256 Plasminogen activator inhibitor-1 inhibitor
10/02/2014US20140296252 1,2,4-triazol-5-ones and analogs exhibiting anti-cancer and anti-proliferative activities
10/02/2014US20140296238 Dihydropyrazoles
10/02/2014US20140296236 Quinolines as fgfr kinase modulators
10/02/2014US20140296232 Compounds for the treatment of mycobacterial infections
10/02/2014US20140296228 Inhibitors of human immunodeficiency virus replication
10/02/2014US20140296208 Kinase inhibitors
10/02/2014US20140296206 Compositions useful for treating disorders related to kit
10/02/2014US20140296202 Substituted piperidinyl compounds useful as gpr119 agonists
10/02/2014US20140296200 6-(5-hydroxy-1h-pyrazol-1-yl)nicotinamide inhibitors of phd
10/02/2014US20140295045 Pyridine Derivatives With Umami Flavour
10/02/2014US20140294873 Small molecule screen for inhibitors of nfat: ap-1: dna interactions
10/01/2014EP2784074A1 Pyrazole compound and use thereof for medical purposes
10/01/2014EP2782912A1 Solid state forms of vilazodone and vilazodone hydrochloride
10/01/2014EP2782903A1 Novel pyrrolidine derivatives as inhibitors of cathepsin
09/2014
09/30/2014US8846952 Detection or quantification of desirable target molecules, novel dyes, composite dyes, and oligonucleotides or polynucleotides comprising such dyes
09/30/2014US8846948 Compounds
09/30/2014US8846947 Benzimidazoles and related analogs as sirtuin modulators
09/30/2014US8846935 Indazoles
09/30/2014US8846933 N-link hydroxamic acid derivatives useful as antibacterial agents
09/30/2014US8846928 Benzamides and nicotinamides as Syk modulators
09/30/2014US8846924 Sulfonamide derivatives of polycyclic dyes used for analytical applications
09/30/2014US8846912 Tartrate salts of quinazoline based EGFR inhibitors containing a zinc binding moiety
09/30/2014US8846910 Matrix metalloproteinase inhibitors
09/30/2014US8846746 Pyrazole compound and pharmaceutical use thereof
09/30/2014US8846727 Haloalkyl heteroaryl benzamide compounds
09/30/2014US8846718 Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxo1-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid
09/30/2014US8846705 Diaminopyrimidines as P2X3 and P2X2/3 antagonists
09/30/2014US8846702 Pyranyl aryl methyl benzoquinazolinone M1 receptor positive allosteric modulators
09/30/2014US8846688 Sodium channel blockers
09/30/2014US8846687 Pyrazine compounds as PI3 kinase inhibitors
09/30/2014US8846681 Pyrimidyl cyclopentanes as AKT protein kinase inhibitors
09/30/2014US8846660 Seven-membered ring compound and pharmaceutical use therefor
09/30/2014US8846655 4-substituted-2-phenoxy-phenylamine delta opioid receptor modulators
09/30/2014US8846125 Enaminocarbonyl compounds and their use
09/30/2014US8846023 Hepatitis C virus inhibitors
09/25/2014WO2014153226A1 Arginine methyltransferase inhibitors and uses thereof
09/25/2014WO2014152588A1 Covalent inhibitors of kras g12c
09/25/2014WO2014152261A1 Substituted 7-deazapurine compounds
09/25/2014WO2014152134A1 Tripeptide epoxy ketone protease inhibitors
09/25/2014WO2014152127A1 Dipeptide and tripeptide epoxy ketone protease inhibitors
09/25/2014WO2014151616A1 Biaryl amide compounds as kinase inhibitors
09/25/2014WO2014151258A1 Substituted pyridine derivatives useful as c-fms kinase inhibitors
09/25/2014WO2014151030A1 Cell proliferation inhibitors and conjugates thereof
09/25/2014WO2014149198A1 Compositions and methods of using the compositions for plaque softening
09/25/2014WO2014147642A1 Substituted fluoranthene-7-carbonitriles as fluorescent dyes for cell imaging applications
09/25/2014WO2014147636A1 5-amino-quinoline-8-carboxamide derivatives as 5-ht4 receptor agonists
09/25/2014WO2014146553A1 Flavonoid derivatives and use thereof
09/25/2014US20140288314 Process of making prostacyclin compounds with linker thiol and pegylated forms
09/25/2014US20140288301 Triazole compounds that modulate hsp90 activity
09/25/2014US20140288129 Prmt1 inhibitors and uses thereof
09/25/2014US20140288110 Ppar modulators
09/25/2014US20140288106 Cycloalkane carboxylic acid derivatives as cxcr3 receptor antagonists
09/25/2014US20140288090 N-arylylmethylindazole modulators of pparg
09/25/2014US20140288088 Inhibitors of the Renal Outer Medullary Potassium Channel
09/25/2014US20140288081 Therapeutic compounds and compositions
09/25/2014US20140288076 Heteroaryl compounds and their uses
09/25/2014US20140288067 Carm1 inhibitors and uses thereof
09/25/2014US20140288065 N,n-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitors
09/25/2014US20140288049 2-Thiopyrimidinones
09/25/2014US20140288048 Heterocyclic compounds and uses thereof
09/25/2014US20140288044 Compositions and therapeutic uses of ikk-related kinase epsilon and tankbinding kinase 1 inhibitors
09/25/2014US20140288041 Aryl- or Heteroaryl-Substituted Benzene Compounds
09/25/2014US20140288034 Compound capable of binding s1p receptor and pharmaceutical use thereof
09/24/2014EP2781513A1 Benzofuran derivatives
09/24/2014EP2781510A1 HIV inhibiting 5,6-substituted pyrimidines
09/24/2014EP2780322A1 Methods and compositions associated with the granulocyte colony-stimulating factor receptor
09/23/2014US8841464 Tri-substituted 2-benzhydryl-5-benzylamino-tetrahydro-pyran-4-ol and 6-benzhydryl-4-benzylamino-tetrahydro-pyran-3-ol analogues, and novel 3,6-disubstituted pyran derivatives
09/23/2014US8841463 Cathepsin C inhibitors
09/23/2014US8841459 3-arylamino pyridine derivatives
09/23/2014US8841458 Compound containing pyridine ring and method for producing halogenated picoline derivative and tetrazolyloxime derivative
09/23/2014US8841336 Tetrazole-substituted arylamides as P2X3 and P2X2/3 antagonists
09/23/2014US8841331 Inhibitors of human immunodeficiency virus replication
09/23/2014US8841313 CCR2 antagonists and uses thereof
09/23/2014US8841305 Activators of the human pyruvate kinase M2 receptor
09/23/2014US8841295 5-lipoxygenase-activating protein (FLAP) inhibitors
09/23/2014US8841290 Substituted tetrahydronaphthalenes, method for the production thereof, and use thereof as drugs
09/23/2014US8841288 Quinolin-4 (1H)-one derivatives as inhibitors of phosphatidylinositol 3-kinases
09/23/2014US8841278 Antiviral compounds
09/23/2014US8840878 Peptidomimetic sulfamide compounds and antiviral uses thereof
09/23/2014CA2782347C Quinoline amide m1 receptor positive allosteric modulators
09/23/2014CA2651987C Piperidinyl derivatives as modulators of chemokine receptor activity
09/23/2014CA2596393C 4-(benzyl)-piperazine-1-carboxylic acid phenylamide derivatives and related compounds as modulators of fatty acid amide hydrolase for the treatment of anxiety, pain and other conditions
09/23/2014CA2582347C Novel benzimidazole derivatives useful as selective androgen receptor modulators (sarms)
09/23/2014CA2575853C Isoindolone compounds and their use as metabotropic glutamate receptor potentiators
09/18/2014WO2014145040A1 Substituted aldehyde compounds and methods for their use in increasing tissue oxygenation
09/18/2014WO2014144761A2 Increasing specificity for rna-guided genome editing
09/18/2014WO2014144169A1 Carm1 inhibitors and uses thereof
09/18/2014WO2014143609A1 Isoquinolines as potassium ion channel inhibitors
09/18/2014WO2014142127A1 Phenylxanthene derivative
09/18/2014WO2014141725A1 Anthracene derivative and organic electroluminescence element using same
09/18/2014WO2014140510A1 Pro-drug compounds
09/18/2014WO2014140310A1 Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy
09/18/2014WO2014140186A1 Oxindole derivatives carrying an oxetane substituent and use thereof for treating vasopressine-related diseases
09/18/2014WO2014140081A1 Substituted bicyclic 1-carboxylic-acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin c
09/18/2014WO2014140078A1 Substituted 2-aza-bicyclo[2.2.1]heptane-3-carboxylic acid (cyano-methyl)-amides inhibitors of cathepsin c
09/18/2014WO2014140076A1 2,3-disubstituted 1 -acyl-4-amino-1,2,3,4-tetrahydroquinoline derivatives and their use as bromodomain inhibitors
09/18/2014WO2014139145A1 Novel pyrimidine and pyridine compounds and usage thereof
09/18/2014WO2013164337A9 Pyrimidine derivatives for the treatment of bacterial diseases
09/18/2014US20140275711 1-(Arylmethyl)-5,6,7,8-tetrahydroquinazolline-2,4-diones and Analogs and the Use Thereof
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 ... 694